Form 8-K CESCA THERAPEUTICS INC. For: Feb 13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Cesca Therapeutics (KOOL) Tops Q2 EPS by 5c
February 16, 2016 4:39 PM ESTCesca Therapeutics (NASDAQ: KOOL) reported Q2 EPS of ($0.02), $0.05 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $3.29 million versus the consensus estimate of $4.32 million.
For earnings history and earnings-related data on Cesca Therapeutics (KOOL) click here.
... More